COVID-19 Archives - Page 2 of 3

Survey Reveals that Study Start-Up is the Latest Target in the March to Virtual Clinical Trials

6 months after COVID-19 hit, one trend has emerged as a dominant theme: making virtual clinical trials a reality. Catch up on the recent survey data.

Posted on 1 Sep 2020
By ArcheMedX Team
In Clinical Research Blog

Interview: Adopting Consumer Tech in Clinical Trials Will Pave the Way for Hybrid and Virtual Trials

We recently spoke with Kemi Olugemo, M.D., Executive Medical Director, Neurology Clinical Development at Akcea Therapeutics. Akcea is a development and commercialization company focused on helping patients with serious diseases. The company is based in Boston, MA. Here are some of the most interesting excerpts from our discussion: ArcheMedX: You’re a neurologist

Posted on 1 Jul 2020
By ArcheMedX Team
In Clinical Research Blog, Interviews

4 Things to Do Now While Clinical Trials Are on Pause

While industry media are reporting that some clinical trials that had been paused are restarting, much of our industry remains stalled due to COVID-19. If you’re among those still in limbo, you may be struggling with how to prioritize your time right now to prepare for restarting. We’ve put together

Posted on 9 Jun 2020
By Kelly Ritch
In Clinical Research Blog

Interview: The People-First Approach to Success in Clinical Trials

We recently spoke with Carl Cook, Vice President of Clinical Operations at Black Diamond Therapeutics, a biotech focused on the discovery and development of precision medicines for cancer. The company is based in Cambridge, MA. We wanted to share these excerpts from the conversation: ArcheMedX: What are the biggest and/or most common

Posted on 8 Jun 2020
By Kelly Ritch
In Clinical Research Blog, Interviews

Contact Tracing: The Vital Importance of a Nationwide Commitment

For months, public health experts have shared a constant refrain, stating that widespread testing and comprehensive contact tracing are essential to stopping the spread of COVID-19. In policy papers, Congressional briefings, and media interviews, they have carefully explained why contact tracing systems should be in place before cases become more

Posted on 21 May 2020
By Joel Selzer
In Clinical Research Blog

It’s Time to Insist on Knowing More about Your Clinical Trial Operations

When discussing how they manage clinical trial staff, industry veterans have often told us that they get the best sense of the readiness of their teams by spending some time in the same room with them, looking them in the eye. Experienced managers will say this allows them to get a gut feeling for

Posted on 7 May 2020
By Kelly Ritch
In Clinical Research Blog

Making a Positive Impact During COVID-19

We have all witnessed the remarkable dedication of our first responders and healthcare workers as they fight each and every day to save the old and young battling COVID-19. There are many more heroes working in meat processing plants, food stores, delivery services, and pharmacies (to name just a few),

Posted on 28 Apr 2020
By Joel Selzer
In Clinical Research Blog

Today’s New Reality in Clinical Trial Readiness

We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an industry, have a good sense of what that means — or what it used to mean. The definition has acquired a whole new dimension in recent days. For example, this post was originally planned to be about a theoretical subset of sites

Posted on 7 Apr 2020
By Kelly Ritch
In Clinical Research Blog

Medical Education in a Time of Physical (Social) Distancing

To say the least, these are unusual times. In the past month, each of us has been faced with both personal and professional decisions that we could not have imagined having to make just weeks earlier. While I can only hope your personal realities are beginning to settle into a

Posted on 30 Mar 2020
By Brian S McGowan, PhD
In Blog, Learning Models & Theory, Medical Education

Our Collective Response to COVID-19

We are all finding ways personally and professionally to meet the challenge posed by COVID-19. Earlier this month, as the threat of COVID-19 was becoming increasingly clear, we at ArcheMedX took decisive action to protect our employees, their families, and our business partners by freezing all travel, ensuring we could work

Posted on 26 Mar 2020
By Joel Selzer
In Clinical Research Blog

Clinical Operations

Commercial Teams

Resources

Medical Education

About Us

Connect with us

Tag : COVID-19

Survey Reveals that Study Start-Up is the Latest Target in the March to Virtual Clinical Trials

Interview: Adopting Consumer Tech in Clinical Trials Will Pave the Way for Hybrid and Virtual Trials

4 Things to Do Now While Clinical Trials Are on Pause

Interview: The People-First Approach to Success in Clinical Trials

Contact Tracing: The Vital Importance of a Nationwide Commitment

It’s Time to Insist on Knowing More about Your Clinical Trial Operations

Making a Positive Impact During COVID-19

Today’s New Reality in Clinical Trial Readiness

Medical Education in a Time of Physical (Social) Distancing

Our Collective Response to COVID-19

Social

Recent News

From Outcomes to Insights: 4 Best Practices in Outcomes Storytelling

Rethinking Training: The Benefits of Embracing ‘Desirable Difficulties’

Contact Us

300 E Main Street, Suite 101 Charlottesville, VA 22902

+1-434-260-1850

Email Us

About Us

Subscribe

Request a Demo